Literature DB >> 15932377

Seasonal and perennial allergic rhinitis: is this classification adherent to real life?

G Ciprandi1, I Cirillo, A Vizzaccaro, M Tosca, G Passalacqua, E Pallestrini, G W Canonica.   

Abstract

BACKGROUND: Allergic rhinitis is traditionally subdivided into seasonal (SAR) and perennial (PAR), although the new definitions of persistent and intermittent were recently proposed. We assessed the validity of the traditional classification in a large group of subjects suffering from allergic rhinitis alone.
METHODS: Young males referred to a Navy Military Hospital for routine fitness visit, and reporting symptoms of rhinitis alone were selected. According to the sensitization they were subdivided into (i) sensitized to pollens only (seasonal, SAR), (ii) to perennial allergens only (perennial, PAR) and (iii) to both (mixed, MAR). Spirometry, methacholine challenge, severity and characteristics of symptoms were assessed in all participants.
RESULTS: Of 19 325 subjects, 2347 had allergic rhinitis. Seventy-two percent of the subjects had MAR, 17% SAR and 11% PAR. Ocular involvement and irritative symptoms were more frequent in SAR (P < 0.03), whereas obstruction was predominant in PAR (P < 0.01). Nasal symptoms varied according to the period of the year in SAR (P < 0.01) and PAR (P < 0.03). An overt bronchial obstruction was detected in 12% of PAR patients, in 7.8% of MAR, and in 4.2% of SAR. forced expiratory volume/1 s was significantly lower during season in SAR patients only (P < 0.05). The FEF25-75 was impaired in 22.5% MAR patients, 21% PAR, and 14% SAR, with a seasonal change in SAR (P < 0.05) and PAR (P < 0.001). Bronchial hyperreactivity was present in 82.2% of PAR, 73.6% of MAR, and 53.5% of SAR, with a seasonal change in SAR (P < 0.001) and MAR (P < 0.05).
CONCLUSIONS: This study provides evidence that up to 80% of allergic rhinitics have a mixed form, and SAR and PAR definitions are poorly adherent to real life. Lung involvement is frequent in patients reporting nose symptoms alone.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15932377     DOI: 10.1111/j.1398-9995.2005.00602.x

Source DB:  PubMed          Journal:  Allergy        ISSN: 0105-4538            Impact factor:   13.146


  18 in total

1.  Association of nasal inflammation and lower airway responsiveness in schoolchildren based on an epidemiological survey.

Authors:  Jun-Ho Myung; Hyun-Jeong Seo; Soo-Jeong Park; Bo-Young Kim; Il-Sang Shin; Jun-Hak Jang; Yun-Kyung Kim; An-Soo Jang
Journal:  Korean J Intern Med       Date:  2015-02-27       Impact factor: 2.884

2.  Triamcinolone Acetonide versus Fluticasone Propionate in the Treatment of Perennial Allergic Rhinitis: A Randomized, Parallel-Group Trial.

Authors:  Alexander V Karaulov; Tamara Vylegzhanina; Andrey Ovchinnikov; Mariia Chernikova; Nataiya Nenasheva
Journal:  Int Arch Allergy Immunol       Date:  2019-03-15       Impact factor: 2.749

3.  Non-interventional study comparing treatment satisfaction in patients treated with antihistamines.

Authors:  Christine De Vos; Krassimir Mitchev; Marie-Etienne Pinelli; Marie-Paule Derde; Rossen Boev
Journal:  Clin Drug Investig       Date:  2008       Impact factor: 2.859

4.  Skin prick test reactivity to common aeroallergens and ARIA classification of allergic rhinitis in patients of Central Greece.

Authors:  K K Anastassakis; A Chatzimichail; I Androulakis; S Charisoulis; Maria Riga; Anna Eleftheriadou; V Danielides
Journal:  Eur Arch Otorhinolaryngol       Date:  2010-01       Impact factor: 2.503

Review 5.  The atopic march: what's the evidence?

Authors:  Jennifer Ker; Tina V Hartert
Journal:  Ann Allergy Asthma Immunol       Date:  2009-10       Impact factor: 6.347

Review 6.  Allergy and the nose.

Authors:  G Ciprandi; G Passalacqua
Journal:  Clin Exp Immunol       Date:  2008-09       Impact factor: 4.330

7.  Characteristics of candidates for allergen immunotherapy.

Authors:  Giorgio Ciprandi; Cristoforo Incorvaia; Ilaria Dell'Albani; Simonetta Masieri; Carmine Cavaliere; Paola Puccinelli; Franco Frati
Journal:  Allergy Rhinol (Providence)       Date:  2013

8.  Seasonal allergic rhinitis: fluticasone propionate and fluticasone furoate therapy evaluated.

Authors:  Harsha H Kariyawasam; Glenis K Scadding
Journal:  J Asthma Allergy       Date:  2010-06-21

9.  Relieving nasal congestion in children with seasonal and perennial allergic rhinitis: efficacy and safety studies of mometasone furoate nasal spray.

Authors:  Eli O Meltzer; Carlos E Baena-Cagnani; Davis Gates; Ariel Teper
Journal:  World Allergy Organ J       Date:  2013-03-04       Impact factor: 4.084

10.  Classification of Allergic Rhinitis: What is Most Suitable in Korea?

Authors:  Hun-Jong Dhong
Journal:  Allergy Asthma Immunol Res       Date:  2013-02-12       Impact factor: 5.764

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.